Global Antimicrobial Peptides Market Size was $313.26 Million in 2023

Global Antimicrobial Peptides Market Overview

According to Global Market Monitor, the global antimicrobial peptides market size was $313.26 million in 2023 with a CAGR of 19.64% from 2023 to 2028.

Antimicrobial peptides (AMPs), also known as host defense peptides, are short and generally positively charged peptides found in a wide variety of life forms from microorganisms to humans. Most AMPs can kill microbial pathogens directly, whereas others act indirectly by modulating the host defense systems.

Antimicrobial Peptides Has Broad Application Prospects. 

Antimicrobial peptides have the advantages of rapid sterilization, broad antibacterial spectrum, less toxicity and side effects, and no immunogenicity. Moreover, due to its special bactericidal mechanism, the inhibited or killed pathogenic microorganisms will not produce resistant strains, and the effect of killing bacteria will not be weakened due to drug resistance. Therefore, antimicrobial peptides are ideal substitutes for antibiotics. The abuse of antibiotics directly leads to the increasingly serious problem of drug-resistant bacterial infections in the world. Therefore, to curb the abuse of antibiotics, most governments around the world will further strictly control the use of antibiotics, spawning scientists' enthusiasm for research on new antimicrobial drugs.

With the development of the world economy, the growth of the total population, and the acceleration of aging, the global pharmaceutical market has maintained steady growth in recent years, and R&D investment in the pharmaceutical industry is on the rise. Having significant, broad-spectrum antibacterial and antitumor activities, as well as the ability to accelerate wound healing and enhance immunity, antimicrobial peptides are gaining popularity as therapeutics for various diseases, making them possible as natural medicine to completely replace traditional antibiotics and antitumor drugs. Studies have shown that antimicrobial peptides can specifically inhibit the growth of certain target tumor cells while being harmless to normal human cells, which brings greater hope for the development of antimicrobial peptides to replace traditional anticancer drugs. In addition, antimicrobial peptides have a certain killing effect on a series of viruses with membrane structures such as HIV and herpes virus. Hence, the market is expected to grow owing to increasing demand for cancer, and HIV treatment.

Company Name	Merck & Co., Inc
Website	www.merck.com
Established Time	1891
Sales Region	Worldwide
Product Introduction	Merck & Co., Inc. provides healthcare solutions worldwide. It operates in four segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The company offers therapeutic agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal, intra-abdominal, hypertension, arthritis and pain, inflammatory, osteoporosis, and fertility diseases.